Skip to main content
. 2023 Jan 3;15(1):161. doi: 10.3390/pharmaceutics15010161

Scheme 3.

Scheme 3

Representation of the experimental protocol for genotoxicity evaluation of Cop and CopNc on A549 cells using the CBMN assay. (A) Morphology of binucleated cells before detachment and staining; (B) Morphology of fixed cells after Giemsa staining.